glp-1 obesity drug news oct 21 2025 Market Obesity GLP-1 Market Size to

While the former act as preservatives for cosmetics, pharmaceuticals, and food products, the latter play an important role in human health as well

No cosmetic, dermatological, therapeutic, or regenerative claims are made or implied

A., Geerlings, S

The future oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other new oral metabolic products will become popular only if they prove themselves capable of producing sustained results in obesity disease, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risks, and metabolic syndromes through their effectiveness and safety

S Afr J Bot 76:612631 Maleki M, Ghorbanpour M, Kariman K (2017) Physiological and antioxidative responses of medicinal plants exposed to heavy metals stress

Our bodies use Niagen (NR), a specialized form of B3, to naturally replenish NAD + levels